Adaptive Physiological Response Systems for Industrial, Transportation, and Recreational Applications
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of implantable drug delivery devices to create adaptive systems that monitor and respond to physiological changes in various industries, enhancing performance, safety, and well-being.
Background and Problem Solved
The original patent focused on treating opioid overdoses using implantable drug delivery devices. However, the core technology has broader potential. Industrial, transportation, and recreational industries face challenges related to fatigue, environmental hazards, and performance optimization. The inventive concept addresses these limitations by applying the implantable drug delivery technology to new use cases, enabling real-time monitoring and targeted interventions.
Detailed Description of the Inventive Concept
The new claims introduce implantable sensor devices that detect changes in body temperature, alertness, and other bodily functions. These sensors trigger drug delivery devices to administer stimulants, antidotes, or performance-enhancing substances in response to abnormal physiological responses. In industrial settings, the system prevents fatigue-related accidents. In transportation, it enhances driver alertness. In recreational contexts, it optimizes athletic performance. The wearable device detects environmental hazards and responds with antidotes.
Novelty and Inventive Step
The inventive concept's novelty lies in its application of implantable drug delivery technology to new industries and use cases, going beyond the original patent's focus on opioid overdoses. The inventive step involves integrating sensor devices with drug delivery systems to create adaptive, real-time response mechanisms.
Alternative Embodiments and Variations
Alternative embodiments may include non-implantable sensor devices, wearable patches, or ingestible sensors. Variations could involve different types of stimulants, antidotes, or performance-enhancing substances, as well as adaptations for specific industries or applications.
Potential Commercial Applications and Market
This inventive concept has significant commercial potential in industries such as manufacturing, logistics, transportation, sports, and healthcare. The market for adaptive physiological response systems is vast, with potential applications in worker safety, driver fatigue prevention, athletic performance optimization, and environmental hazard response.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61M5/14276 |
| A | A61 | A61B5/4839 |
| A | A61 | A61B5/4845 |
| A | A61 | A61B5/4848 |
| A | A61 | A61K9/0024 |
| A | A61 | A61K9/0097 |
| A | A61 | A61M5/44 |
| A | A61 | A61M31/002 |
| A | A61 | A61M37/0069 |
| A | A61 | A61B5/01 |
| A | A61 | A61F2250/0068 |
| A | A61 | A61K31/485 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device technology, specifically implantable drug delivery systems and physiological monitoring, involving biomedical engineering, sensor technologies, and pharmaceutical delivery mechanisms
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with expertise in implantable drug delivery systems, sensor integration, physiological monitoring, and cross-disciplinary medical technology applications
Obviousness Rationale
A person having ordinary skill would recognize that the source patent's implantable drug delivery device provides a foundational technology that can be readily adapted to multiple physiological monitoring and intervention scenarios. The core technological principles of detecting bodily changes and responding with targeted drug delivery are inherently extensible across different industrial, medical, and performance contexts. The PTD's variations represent predictable engineering modifications that leverage the source patent's fundamental technological framework.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,758 |
|---|---|
| Title | Drug delivery device and method |
| Assignee(s) | Purdue Research Foundation |